Acute effects of ketamine and esketamine on cognition in healthy subjects: A meta-analysis

• Published in: Progress in neuro-psychopharmacology & biological psychiatry 2022-08, Vol.118, p.110575-110575, Article 110575
• Main Authors: Zhornitsky, Simon, Tourjman, Valérie, Pelletier, Julie, Assaf, Roxane, Li, Chiang-Shan R., Potvin, Stéphane
• Format: Article
• Language: English
• Subjects: Acute administration; Cognition; Ketamine; meta-analysis
• ISSN: 0278-5846; 1878-4216
• DOI: 10.1016/j.pnpbp.2022.110575

Impairment in cognition is frequently associated with acute ketamine administration. However, some questions remain unanswered as to which deficits are most prominent and what variables modulate these effects. A literature search yielded 56 experimental studies of acute ketamine administration that assessed cognition in 1041 healthy volunteers. A multivariate meta-analysis was performed, and effect sizes were estimated for eleven cognitive domains: attention, executive function, response inhibition, social cognition, speed of processing, verbal / language, verbal learning, verbal memory, visual learning & memory, visuospatial abilities, and working memory. There were small-to-moderate impairments across all cognitive domains. Deficits in verbal learning / memory were most prominent, whereas response inhibition was the least affected. Meta-regression analysis revealed that the negative effects of ketamine on cognition are dependent on infusion dose and plasma level, but unaffected by enantiomer type, route of administration, sex or age. A publication bias was observed. Acute ketamine broadly impairs cognition across all domains among healthy individuals. Verbal learning and memory figures most prominently in cognitive impairment elicited by acute ketamine administration. •Acute ketamine affects multiple cognitive domains in healthy individuals.•The most prominent ketamine-induced deficits are in verbal learning and memory.•The negative effects of acute ketamine administration are dose-dependent.